Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Sugar molecules to help detect tumors

Dear Sir or Madam,

When cancer is detected, the question often arises, why the human immune system does not attack the tumor cells. This seems to be partly due to the protein Galectin-1, which can be found in very high quantities on tumor cells and virtually hides them. Scientists have now designed sugar molecules which bind to this protein and thus help to render it visible. Read more in our current
Top News.

I wish you a great week

Julia Unverzagt
Editorial team MEDICA-tradefair.com


MEDICA Trade Fair with Forums and Conferences
Monday to Thursday
13 to 16 November 2017
Düsseldorf, Germany

Table of Contents

Topic of the Month: Exasens
Newsletter Service
RSS Service
Newsletter Archive

USA Pavilion Launches FTR4H LAB

Image: Computer generated image of a trade fair stand
Powered by MEDICA, FTR4H (Future for Healthcare) is an international platform – showcasing and exploring how digital transformation affects the healthcare industry. FTR4H serves as a Think Tank and Definer, connecting global digital health ecosystems with global markets and the World of MEDICA. This year the USA Pavilion in hall 16 will feature it’s first-ever FTR4H LAB, featuring USA-based innovators and visionaries showcasing and demonstrate their cutting edge technologies and solutions in the digital and mobile healthcare fields.
For details click here or email Messe Düsseldorf North America, attention Ryan Klemm: rklemm@mdna.com.

Molecular Microsystems: Preventing Exacerbations of Asthma and COPD

Topic of the Month

Image: woman holding a sketch of a human lung; Copyright: panthermedia.net/Monkeybusiness
An increasing percentage of the world population suffers from chronic inflammatory disorders of the respiratory system. Acute attacks often lead to a worsening of the disease and considerably reduce the patient’s lung volume. Nine institutes of a research alliance under the Leibniz Institute umbrella are working on technologies designed to predict and thus prevent exacerbations.
Read more in our Topic of the Month:
Molecular Microsystems: Preventing Exacerbations of Asthma and COPD
Point-of-care solutions – uncomplicated and fast
To top

Company News

Cyber Science 3D and Gale Partner to Create 3D Science Products for the Library Market

VIVED

CORALVILLE, Iowa, Nov. 18, 2015 — The partnership will pair Gale’s content expertise with Cyber Science’s 2D and 3D interactive capabilities in multiple science subjects. “We have been...
read more
To top

Company News

25 years BYTEC

BYTEC Medizintechnik GmbH

This year BYTEC Medizintechnik GmbH celebrates her 25-year-old existence. President and CEO Paul W. Coenen: „We cover with the rising demands in the „medicine device world“ and are steadily growing...
read more
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.
To top

beta-web GmbH - Partner of Messe Düsseldorf

Advertising Opportunities

As an official partner of Messe Düsseldorf, beta-web markets exclusive forms of advertisements to exhibitors of the MEDICA.

You want to be part of the newsletter and reach over 30.000 interested readers with your advertising message? Then contact us at medica@beta-web.de or call us: 0049 – 228 9193735.

For more information on our available forms of advertisements, please see our Media Kit.
Website of beta-web GmbH
To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 (0)211 / 4560-01
Fax: +49 (0)211 / 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Werner M. Dornscheidt (Chairman), Hans Werner Reinhard, Joachim Schäfer, Bernhard Stempfle

Chairman of Supervisory Board: Mayor Thomas Geisel

Facebook Twitter LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.